Embolization Particle Market Size is Expected to Progress at CAGR of 10.87% to Achieve USD 3,918.02 Million by 2032

According to the report, The global Embolization Particle market size accrued earnings worth approximately USD 1547.89 Million in 2023 and is predicted to gain revenue of about USD 3,918.02 Million by 2032, is set to record a CAGR of nearly 10.87% over the period from 2024 to 2032.

Zion Market Research has published a new report titled “Embolization Particle Market by Particle Type (Microspheres, Particles, Drug Eluting Beads, and Radio Embolic Microspheres), by Application (Trauma Embolization, Liver Tumor Embolization, Prostatic Artery Embolization, Uterine Fibroid Embolization, and Others): Global Industry Perspective, Comprehensive Analysis, and Forecast, 2017–2024”.

Request Free Sample

Embolization particles are irregular and small flakes of polyvinyl alcohol that are used for blood occlusion. These particles are injected into blood vessels to cut the blood supply to tumors, which, in turn, shrink the malformation. These are also used to stop bleeding from wounds during trauma. Embolization particles are used to treat cancers that cannot be removed by surgery, due to their huge size and proximity to vital organs that can be life-threating for the patient if operated upon. Embolization therapy is performed by interventional radiologists and offers many benefits as compared to conventional surgical treatments.

There increased prevalence of cancers and tumors is likely to drive the embolization particle market over the forecast time period. As per the National Cancer Institute 2018 Report, there were around 1,735,350 new cancer cases in the U.S. This number is expected to reach 23.6 million by 2030. Moreover, substantial technological advancements made in the healthcare industry are leading to various new product launches for the treatment of varied chronic conditions. Furthermore, the increasing awareness among people about embolization particle is likely to lead to an increased demand for embolization particle over the estimated time period. Moreover, the increase in the interventional procedure and rise in the number of minimally invasive surgeries due to positive and effective results are expected to support the embolization particle market in the years ahead. However, the lack of skilled interventional cardiologists might limit the embolization particle market in the future.

Request Customization

Types of Embolization Particles:

• Microspheres: Explore the dominance of microsphere embolization particles, including polyvinyl alcohol (PVA) and embospheres, in various embolization procedures due to their versatility and efficacy.
• Liquid Embolics: Discuss the emergence of liquid embolics such as Onyx and ethylene vinyl alcohol copolymer (EVOH) for the treatment of vascular lesions and arteriovenous malformations (AVMs), offering precise control and conformability.
• Drug-Eluting Particles: Cover the innovative use of drug-eluting particles, incorporating therapeutic agents such as chemotherapy drugs or radioisotopes, for targeted delivery and sustained release within the vasculature.

3. Technological Innovations:

• Next-Generation Embolization Devices: Explore advancements in embolization device design, including improved delivery systems, enhanced visibility under imaging guidance, and customizable embolic agent loading capacities.
• Image-Guided Navigation: Discuss the integration of advanced imaging modalities such as fluoroscopy, magnetic resonance imaging (MRI), and cone-beam computed tomography (CBCT) for real-time visualization and precise embolization guidance.
• Biocompatible Materials: Highlight research efforts towards developing biocompatible embolization particles with reduced inflammatory response and improved long-term outcomes for patients.

4. Market Segmentation by Application:

• Oncology: Discuss the use of embolization particles in the treatment of primary and metastatic liver cancer, as well as other solid tumors, through transarterial chemoembolization (TACE) and radioembolization (TARE) procedures.
• Interventional Radiology: Explore applications of embolization particles in non-oncological interventions, including uterine fibroid embolization (UFE), peripheral vascular embolization, and embolization of vascular malformations.
• Neurointerventional Procedures: Cover the role of embolization particles in the management of cerebral aneurysms, arteriovenous malformations (AVMs), and other neurovascular conditions, offering minimally invasive alternatives to surgery.

5. Regulatory Landscape and Reimbursement:

• FDA Approval Process: Discuss regulatory considerations for embolization particles, including premarket approval (PMA) requirements and the 510(k) clearance process for new devices.
• Reimbursement Policies: Analyze reimbursement trends for embolization procedures and associated costs, highlighting coding guidelines, coverage determinations, and payer policies impacting reimbursement rates.

6. Competitive Landscape:

• Key Players: Profile leading companies in the embolization particle market, including manufacturers of embolic agents, medical device companies, and research institutions.
• Market Strategies: Evaluate strategies adopted by market players to gain a competitive edge, such as product development initiatives, strategic collaborations, and geographic expansion efforts.

7. Future Outlook:

• Emerging Applications: Explore emerging applications of embolization particles, such as targeted drug delivery, tissue ablation, and regenerative medicine, opening new avenues for market growth.
• Technological Advancements: Anticipate future technological advancements in embolization devices and embolic agents, including the integration of artificial intelligence (AI), robotics, and nanotechnology for enhanced precision and efficacy.
• Market Expansion: Assess opportunities for market expansion in emerging regions, driven by increasing healthcare infrastructure development, rising healthcare expenditure, and growing awareness of minimally invasive treatment options.

The embolization particle market is segmented on the basis of particle type and application. Based on particles type, the embolization particle market is segmented into microspheres, particles, drug-eluting beads (DEBs), and radio-embolic microspheres. Particles are expected to dominate the market in the upcoming years. Based on application, the embolization particle market is segmented into trauma embolization, liver tumor embolization, prostatic artery embolization, uterine fibroid embolization, and others. Trauma embolization is likely to grow rapidly in the estimated time period.

By region, this global market includes North America, Europe, Asia Pacific, Latin America, the Middle East, and Africa. North America is likely to dominate the embolization particle market in the upcoming years, owing to the presence of developed countries and advanced healthcare infrastructure. Europe is expected to closely follow North America in terms of revenue. The Asia Pacific region is projected to grow rapidly owing to the presence of developing economies, such as India and China. Latin American and the Middle Eastern and African regions are expected to grow moderately in the forecast time period.

Buy Now

Some major players of the embolization particle market include -

• Sirtex Medical Limited
• Boston Scientific Corporation
• Merit Medical Systems
• BTG International Ltd.
• Cook Medical
• Interface BIOmaterials
• among others

This report segments the global embolization particle market as follows:

Global Embolization Particle Market: Particle Type Analysis

• Microspheres
• Particles
• Drug-Eluting Beads (DEBs)
• Radio-Embolic Microspheres

Global Embolization Particle Market: Application Analysis

• Trauma Embolization
• Liver Tumor Embolization
• Prostatic Artery Embolization
• Uterine Fibroid Embolization
• Others

Global Embolization Particle Market: Regional Analysis

• North AmericaThe U.S.
• EuropeUKFranceGermany
• Asia PacificChinaJapanIndia
• Latin AmericaBrazil
• The Middle East and Africa

About Us:

Zion Market Research is an obligated company. We create futuristic, cutting-edge, informative reports ranging from industry reports, the company reports to country reports. We provide our clients not only with market statistics unveiled by avowed private publishers and public organizations but also with vogue and newest industry reports along with pre-eminent and niche company profiles. Our database of market research reports comprises a wide variety of reports from cardinal industries. Our database is been updated constantly in order to fulfill our clients with prompt and direct online access to our database. Keeping in mind the client’s needs, we have included expert insights on global industries, products, and market trends in this database. Last but not the least, we make it our duty to ensure the success of clients connected to us — after all — if you do well, a little of the light shines on us.

Contact Us:

Zion Market Research 244 Fifth Avenue, Suite N202 New York, 10001, United States Tel: +49–322 210 92714 USA/Canada Toll-Free №1–855–465–4651 Email: sales@zionmarketresearch.com Website: https://www.zionmarketresearch.com